Abstract
7504 Background: Extensive stage small cell lung cancer (ES-SCLC) is a disease with high mortality. SCLC is initially exquisitely sensitive to chemotherapy with carboplatin and etoposide (CE), cons...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
